English court says Roche did not infringe insulin pump patents

The English High Court has cleared Roche of patent infringement claims over its line of insulin pumps but shot down the pharma giant’s attempt to invalidate the plaintiff’s patent.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Swiss big pharma settles patent dispute with Insulet

12 July 2022 The dispute over a patent covering a blood glucose level monitor ends with a multimillion-dollar payment and a licence agreement.

Big Pharma

Roche and Bluebird settle ‘Spark’ TM suit

19 May 2022 Roche subsidiary Spark Therapeutics has settled a lawsuit with rival gene-therapy company Bluebird Bio, which it had accused of infringing its “Spark” trademarks when marketing treatment for sickle-cell disease.

Big Pharma

Roche asks court for halt of Novartis unit’s generic launch

4 April 2022 Roche’s subsidiary Genentech has asked a Delaware court to block two of Novartis’ units from selling a generic version of the blockbuster lung-disease drug Esbriet.

More features

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

UK gets new IP minister following cabinet reshuffle

English court says Roche did not infringe insulin pump patents

More on this story

Editor's picks

Editor's picks

More features